Matthew Thomas Perraton - Net Worth and Insider Trading
Matthew Thomas Perraton Net Worth
The estimated net worth of Matthew Thomas Perraton is at least $243 dollars as of 2024-11-13. Matthew Thomas Perraton is the Director of Theralase Technologies Inc and owns about 900 shares of Theralase Technologies Inc (TSXV:TLT) stock worth over $243. Details can be seen in Matthew Thomas Perraton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Thomas Perraton has not made any transactions after 2024-01-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Thomas Perraton
Matthew Thomas Perraton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Thomas Perraton owns 1 companies in total, including Theralase Technologies Inc (TSXV:TLT) .
Click here to see the complete history of Matthew Thomas Perraton’s form 4 insider trades.
Insider Ownership Summary of Matthew Thomas Perraton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:TLT | Theralase Technologies Inc | 2024-01-04 | Director |
Matthew Thomas Perraton Latest Holdings Summary
Matthew Thomas Perraton currently owns a total of 1 stock. Matthew Thomas Perraton owns 900 shares of Theralase Technologies Inc (TSXV:TLT) as of January 4, 2024, with a value of $243.
Latest Holdings of Matthew Thomas Perraton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:TLT | Theralase Technologies Inc | 2024-01-04 | 900 | 0.27 | 243 |
Holding Weightings of Matthew Thomas Perraton
Matthew Thomas Perraton Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Thomas Perraton has made a total of 5 transactions in Theralase Technologies Inc (TSXV:TLT) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Theralase Technologies Inc is the acquisition of 900 shares on January 4, 2024, which cost Matthew Thomas Perraton around $176.
Insider Trading History of Matthew Thomas Perraton
- 1
Matthew Thomas Perraton Trading Performance
GuruFocus tracks the stock performance after each of Matthew Thomas Perraton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Thomas Perraton is -13.51%. GuruFocus also compares Matthew Thomas Perraton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Thomas Perraton within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Thomas Perraton's insider trading performs compared to the benchmark.
Performance of Matthew Thomas Perraton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.51 |  | | | | |
| Relative Return to S&P 500(%) | -19.27 | | | | | |
Matthew Thomas Perraton Ownership Network
Ownership Network List of Matthew Thomas Perraton
Ownership Network Relation of Matthew Thomas Perraton
Matthew Thomas Perraton Owned Company Details
What does Theralase Technologies Inc do?
Who are the key executives at Theralase Technologies Inc?
Matthew Thomas Perraton is the Director of Theralase Technologies Inc. Other key executives at Theralase Technologies Inc include 10% Security Holder & Director & Senior Officer Roger John Dumoulin-White , Senior Officer Kristina Maria Hachey , and Senior Officer Arkady Mandel .
Theralase Technologies Inc (TSXV:TLT) Insider Trades Summary
Over the past 18 months, Matthew Thomas Perraton made 1 insider transaction in Theralase Technologies Inc (TSXV:TLT) with a net purchase of 900.
In summary, during the past 3 months, insiders sold 0 shares of Theralase Technologies Inc (TSXV:TLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theralase Technologies Inc (TSXV:TLT) were sold and 900 shares were bought by its insiders, resulting in a net purchase of 900 shares.
Theralase Technologies Inc (TSXV:TLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theralase Technologies Inc Insider Transactions
Matthew Thomas Perraton Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Thomas Perraton. Currently GuruFocus does not have mailing address information for Matthew Thomas Perraton.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
